Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediMush is an Israeli biotechnology company specializing in the research, development, and cultivation of medicinal mushrooms for therapeutic and nutraceutical applications. The company utilizes advanced solid-state fermentation and controlled environment technologies to produce high-quality, standardized extracts from species such as Cordyceps militaris and Ganoderma lucidum. MediMush focuses on the bioactive compounds within these fungi, targeting immune system modulation and providing supportive care in oncology. Their business model encompasses both the supply of raw materials to the pharmaceutical industry and the development of proprietary health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediMush.